Showing results (1061-1070 of 5,224) with videos related to
Sort By:
Pageof 523
Antiviral Research|June 29, 2014
Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challengeSyed Khader Syed Musthaq, S Rajesh Kumar, Milene Szyporta, et al.Antiviral Research|July 4, 2014
Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site featuresJian Lei, Jeroen R Mesters, Christian Drosten, et al.Antiviral Research|December 1, 1989
Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirinH L Lucia, D H Coppenhaver, S BaronAntiviral Research|August 14, 2012
A small molecule screen in yeast identifies inhibitors targeting protein-protein interactions within the vaccinia virus replication complexOlivier Flusin, Laurent Saccucci, Céline Contesto-Richefeu, et al.Antiviral Research|June 28, 2020
Modeling based response guided therapy in subjects with recent hepatitis C infectionEvan Gorstein, Marianne Martinello, Alexander Churkin, et al.Antiviral Research|April 18, 2015
A spiroketal-enol ether derivative from Tanacetum vulgare selectively inhibits HSV-1 and HSV-2 glycoprotein accumulation in Vero cellsÁngel L Álvarez, Solomon Habtemariam, Ahmed E Abdel Moneim, et al.Antiviral Research|April 22, 2021
Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapyIsabela Gomes Ribeiro, Jordana Grazziela Alves Coelho-Dos-Reis, Jordana Rodrigues Barbosa Fradico, et al.Antiviral Research|April 24, 2021
A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymeraseJianyuan Zhao, SaiSai Guo, Dongrong Yi, et al.Antiviral Research|April 18, 2021
Prior transient exposure to interleukin-21 delivered by recombinant adeno-associated virus vector protects mice from hepatitis B virus persistenceZhongliang Shen, Zixiang Gao, Chenjian Gu, et al.Antiviral Research|September 18, 2012
The maximum potential market for dengue drugs V 1.0Geoffrey Dow, Eric MoraPageof 523